Migami focuses its resources on utilizing unique, groundbreaking delivery systems to develop the next generation of anti-aging and health products.  By entering various international partnerships, Migami harnesses established domestic and international distribution networks to launch their innovative products worldwide.  It is the rights to such groundbreaking technology that has attracted potential investors throughout the second half of 2007 and 2008, helping Migami achieve its goal of maximizing shareholder value and general portfolio desirability.

MIGAMI is in a very attractive strategic position to take advantage of the Pacific Rim's vibrant growth of its population and its increasing interest in Western technologies and products. MIGAMI will develop products that meet the needs of this dynamic market, and reinforce MIGAMI's relatively unique understanding and sensitivity to the region's culture and business practices. MIGAMI has forged strategic relationships with a broad base of key Pacific Rim professionals in business and government.

Our strengths include:

Proven track record in acquiring technology and product rights

Solid ability to fine-tune the acquired technology (eg, via further development, reformulations, packaging, etc.)

The rights to lab-tested technology aimed at revolutionizing drug delivery systems

Firm commitment to protecting IP in Asia

Migami derives its revenue from distributing licensing rights, royalty fees from licensed products and general pharmaceutical manufacturing partnerships